Autologous hematopoietic cell transplantation for high-risk ALL

Bone Marrow Transplantation

Volumn 46, Issue 3, 2011, Pages 460-461

  Linker, C ^a   Damon, L ^a   Martin, T ^a   Blume, K ^b   Forman, S ^c   Snyder, D ^c   Wolf, J ^b,d   Negrin, R ^b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b STANFORD UNIVERSITY MEDICAL CENTER   (United States)

^c CITY OF HOPE NATIONAL MEDICAL CENTER   (United States)

^d Alta Bates Medical Center   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOPHOSPHAMIDE; CYTARABINE; ETOPOSIDE; GRANULOCYTE COLONY STIMULATING FACTOR; IMATINIB;

ACUTE LYMPHOCYTIC LEUKEMIA; ADD ON THERAPY; ADOLESCENT; ADULT; AIR EMBOLISM; AUTOLOGOUS HEMATOPOIETIC STEM CELL TRANSPLANTATION; CANCER CHEMOTHERAPY; CANCER MORTALITY; CANCER RADIOTHERAPY; CANCER REGRESSION; CANCER SURVIVAL; CD34 SELECTION; CHROMOSOME TRANSLOCATION 11; CHROMOSOME TRANSLOCATION 22; CHROMOSOME TRANSLOCATION 4; CHROMOSOME TRANSLOCATION 9; CLINICAL ARTICLE; CONTINUOUS INFUSION; CYTOGENETICS; EVENT FREE SURVIVAL; FOLLOW UP; HIGH RISK PATIENT; HUMAN; LETTER; LEUKOCYTE COUNT; MONOSOMY 7; MORTALITY; MUCOSA INFLAMMATION; MULTIPLE CYCLE TREATMENT; OUTCOME ASSESSMENT; PHILADELPHIA 1 CHROMOSOME; PRIORITY JOURNAL; RADIATION DOSE; SURVIVAL TIME; TRANSPLANT RELATED MORTALITY; TREATMENT RESPONSE; WHOLE BODY RADIATION;

ADULT; FEMALE; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; MALE; MIDDLE AGED; PRECURSOR CELL LYMPHOBLASTIC LEUKEMIA-LYMPHOMA; RISK FACTORS; TRANSPLANTATION, AUTOLOGOUS; YOUNG ADULT;

EID: 79952534081     PISSN: 02683369     EISSN: 14765365     Source Type: Journal    
DOI: 10.1038/bmt.2010.125     Document Type: Letter

References (10)

1. ASBMT Executive Committee. ASBMT Position Statement: The role of cytotoxic therapy with hematopoietic stem cell transplantation in the treatment of acute lymphoblastic leukemia in adults. Biol Blood Marrow Transplant 2006; 12: 368-369.
2. Goldstone AH, Richards SM, Lazarus HM, Tallman MS, Buck G, Fieldiing AK et al. In adults with standard-risk acute lymphoblastic leukemia, the greatest benefit is achieved from a matched sibling allogeneic transplantation in first complete remission, and an autologous transplantation is less effective than conventional consolidation/maintenance chemotherapy in all patients: final results of the International ALL Trial (MRC UKALL XII/ECOG E2993). Blood 2008; 111: 1827-1833. (Pubitemid 351451489)
3. Fiere D, Lepage E, Sebban C, Boucheix C, Gisselbrecht C, Vernant JP et al. Adult acute lymphoblastic leukemia: a multicentric randomized trial testing bone marrow transplan-tation as postremission therapy. The French Group on Therapy for Adult Acute Lymphoblastic Leukemia. J Clin Oncol 1993; 11: 1990-2001. (Pubitemid 23304626)
4. Thomas X, Boiron J-M, Huguet F, Dombret H, Bradstock K, Vey N et al. Outcome of treatment in adults with acute lymphoblastic leukemia: analysis of the LALA-94 trial. J Clin Oncol 2004; 22: 4075-4086. (Pubitemid 41185176)
5. Dhedin N, Dombret H, Thomas X, Lheritier V, Boiron J-M, Rigal-Huguet F et al. Autologous stem cell transplantation in adults with acute lymphoblastic leukemia in first complete remission: analysis of the LALA-85,-87 and-94 trials. Leukemia 2005; 20: 336-344.
6. Linker CA, Ries CA, Damon LE, Rugo HS, Wolf JL, Topolsky D et al. Autologous stem cell transplantation for acute myeloid leukemia in first remission. Biol Blood Marrow Transplant 2000; 6: 50-57.
7. Negrin R, Kusnierz-Glaz C, Still B, Schriber JR, Chao NJ, Long GD et al. Transplantation of enriched and purged peripheral blood progenitor cells from a single apheresis product in patients with non-Hodgkin's lymphoma. Blood 1995; 85: 3334-3341.
8. Blume K, Forman S, O'Donnell M, Doroshow JH, Krance RA, Nademanee AP et al. Total body irradiation and high-dose etoposide: a new preparatory regimen for bone marrow transplantation in patients with advanced hematologic malignancies. Blood 1987; 69: 1015-1020. (Pubitemid 17080917)
9. Marks DI, Forman SJ, Blume KG, Perez WS, Weisdorf DJ, Keating A et al. A comparison of cyclophosphamide and total body irradiation with etoposide and total body irradiation as conditioning regimens for patients undergoing sibling allo-grafting for acute lymphoblastic leukemia in first or second complete remission. Biol Blood Marrow Transplant 2006; 12: 438-453. (Pubitemid 43380961)
10. Wetzler M, Stock W, Donohue KA, Owzar K, Sher DA, Hoke EC et al. Autologous stem cell transplantation following sequential chemotherapy and imatinib for adults with newly diagnosed Philadelphia-chromosome positive acute lympho-blastic leukemia\CALGB study 10001. Blood 2007; 110: 843a-844a.